Puma Biotechnology (PBYI) Treasury Shares (2014 - 2026)

Puma Biotechnology's Treasury Shares history runs 13 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• Quarterly Treasury Shares rose 8.63% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 8.63% YoY) and the FY2025 annual result came in at $1.3 million, up 3.53% from the prior year.
• Treasury Shares was $2.0 million for Q1 2026 at Puma Biotechnology, up from $1.3 million in the prior quarter.
• Across five years, Treasury Shares topped out at $2.4 million in Q1 2023 and bottomed at $1.3 million in Q4 2024.
• A 5-year average of $1.8 million and a median of $1.8 million in 2025 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares climbed 24.33% — and 2024, when it retreated 22.69%.
• Puma Biotechnology's Treasury Shares stood at $1.5 million in 2022, then rose by 8.2% to $1.6 million in 2023, then decreased by 20.65% to $1.3 million in 2024, then increased by 3.53% to $1.3 million in 2025, then surged by 51.17% to $2.0 million in 2026.
• Business Quant data shows PBYI's Treasury Shares at $2.0 million in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.